BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33239916)

  • 1. Combined Therapy Can Improve the Outcomes of Breast Cancer with Isolated Supraclavicular Lymph Node Involvement.
    Ma T; Mao Y; Wang H
    Cancer Manag Res; 2020; 12():11857-11869. PubMed ID: 33239916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of supraclavicular surgery plus radiotherapy versus radiotherapy alone in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis: A multicenter retrospective study.
    Song YC; Kong J; Li N; Liu XL; Li XH; Zhu LY; Wang YW; Fang H; Jing H; Tang Y; Li YX; Wang XH; Zhang J; Wang SL
    Radiother Oncol; 2023 Jun; 183():109639. PubMed ID: 36990395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Role of Supraclavicular lymph node dissection in Breast Cancer Patients with Synchronous Ipsilateral Supraclavicular Lymph Node Metastasis].
    Zhang W; Qi XM; Chen AX; Zhang P; Cao XC; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):374-379. PubMed ID: 28535656
    [No Abstract]   [Full Text] [Related]  

  • 4. Supraclavicular lymph node dissection with radiotherapy versus radiotherapy alone for operable breast cancer with synchronous ipsilateral supraclavicular lymph node metastases: a real-world cohort study.
    Ai X; Wang M; Li J; Hu Y; Hou L; Zheng X; Yan Y; Pan Q; Jin Y; Liu W; Tan X; Tian Y; Zhang Y; Tang P; Jiang J
    Gland Surg; 2020 Apr; 9(2):329-341. PubMed ID: 32420257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggressive Surgical Excision of Supraclavicular Lymph Node Did Not Improve the Outcomes of Breast Cancer With Supraclavicular Lymph Node Involvement (KROG 16-14).
    Kim K; Kim SS; Shin KH; Kim JH; Ahn SD; Choi DH; Park W; Lee SY; Chun M; Kim JH; Kim YB; Cha J; Park HJ; Lee DS; Jung W
    Clin Breast Cancer; 2020 Feb; 20(1):51-60. PubMed ID: 31629642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of aggressive locoregional surgery in treatment strategies for ipsilateral supraclavicular lymph node metastasis of breast cancer: a real-world cohort study.
    Feng K; Xing Z; Dai Q; Cheng H; Wang X
    Front Mol Biosci; 2023; 10():1248410. PubMed ID: 37916188
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison between surgery plus radiotherapy and radiotherapy alone in treating breast cancer patients with ipsilateral supraclavicular lymph node metastasis.
    Sun XF; Wang YJ; Huang T; Niu LJ; Zhang Q; Liu ZZ
    Gland Surg; 2020 Oct; 9(5):1513-1520. PubMed ID: 33224826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of surgery on locoregional treatment of patients with breast cancer newly diagnosed with ipsilateral supraclavicular lymph node metastasis.
    Liu BW; Chen LX; Ma K; Chi JR; Yang ZJ; Yu Y; Cao XC
    J Cancer Res Ther; 2022 Apr; 18(2):496-502. PubMed ID: 35645120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary Outcomes After Multimodality Therapy in Patients With Breast Cancer Presenting With Ipsilateral Supraclavicular Node Involvement.
    Diao K; Andring LM; Barcenas CH; Singh P; Carisa Le-Petross H; Reed VK; Reddy JP; Bloom ES; Ahmad NR; Mayo LL; Perkins GH; Mitchell MP; Nead KT; Tereffe W; Smith BD; Woodward WA
    Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):66-74. PubMed ID: 34710521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study of different local treatments in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis.
    Chang XZ; Yin J; Sun J; Zhang XH; Cao XC
    J Cancer Res Ther; 2013 Nov; 9 Suppl():S158-61. PubMed ID: 24516053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Regional Nodal Irradiation for Breast Cancer Patients with Supraclavicular and/or Internal Mammary Lymph Node Involvement: A Multicenter, Retrospective Study (KROG 16-14).
    Kim K; Jeong Y; Shin KH; Kim JH; Ahn SD; Kim SS; Suh CO; Kim YB; Choi DH; Park W; Cha J; Chun M; Lee DS; Lee SY; Kim JH; Park HJ; Jung W
    Cancer Res Treat; 2019 Oct; 51(4):1500-1508. PubMed ID: 30913866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contralateral Axillary Lymph Node Metastasis of Breast Cancer: Retrospective Analysis and Literature Review.
    Zhang L; Wang XZ; Li C; Yu Q; Liu Z; Yu ZY
    Front Oncol; 2022; 12():869397. PubMed ID: 35494019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance.
    Wernicke AG; Goodman RL; Turner BC; Komarnicky LT; Curran WJ; Christos PJ; Khan I; Vandris K; Parashar B; Nori D; Chao KS
    Breast Cancer Res Treat; 2011 Feb; 125(3):893-902. PubMed ID: 20853176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loco-regional therapy for isolated locoregional lymph node recurrence of breast cancer: focusing on surgical treatment with combined therapy.
    Terata K; Yamaguchi A; Ibonai A; Imai K; Wakita A; Sato Y; Motoyama S; Minamiya Y
    Transl Cancer Res; 2020 Aug; 9(8):5038-5043. PubMed ID: 35117869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical Lymph Node Involvement above the Supraclavicular Fossa in Breast Cancer: Comparison with Stage IIIC (KROG 18-02).
    Kim JS; Kim K; Shin KH; Kim JH; Ahn SD; Kim SS; Kim YB; Chang JS; Choi DH; Park W; Kim TH; Chun M; Cha J; Kim JH; Lee DS; Lee SY; Park HJ
    J Breast Cancer; 2020 Apr; 23(2):194-204. PubMed ID: 32395378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Construction of a nomogram prediction model for pathological complete response (pCR) of ipsilateral supraclavicular lymph node after neoadjuvant chemotherapy for breast cancer with first diagnosis of ipsilateral supraclavicular lymph node metastasis].
    Lyu MH; Jiao DC; Wu JZ; Tian PQ; Ma YZ; Liu ZZ; Chen XC
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):160-166. PubMed ID: 35184460
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment Outcome of Breast Cancer with Pathologically Proven Synchronous Ipsilateral Supraclavicular Lymph Node Metastases.
    Jung J; Kim SS; Ahn SD; Lee SW; Ahn SH; Son BH; Lee JW; Choi EK
    J Breast Cancer; 2015 Jun; 18(2):167-72. PubMed ID: 26155293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome in patients with four or more positive lymph nodes treated with conservative surgery and radiation therapy.
    Mehta K; Haffty BG
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):679-85. PubMed ID: 8690633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of nodal involvement region in clinical stage IIIc breast cancer patients who received primary systemic treatment, surgery, and radiotherapy.
    Noh JM; Kim KH; Park W; Suh CO; Huh SJ; Choi DH; Keum KC; Kim YB
    Breast; 2015 Oct; 24(5):637-41. PubMed ID: 26283599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant therapy combined with surgery is superior to chemoradiotherapy in esophageal squamous cell cancer patients with resectable supraclavicular lymph node metastasis: a propensity score-matched analysis.
    Yu Y; Xu L; Chen X; Li H; Liu Q; Zhang R; Xie H; Chen Y; Yuan L; Tan B; Li Y; Xing W
    Ann Transl Med; 2022 Mar; 10(6):349. PubMed ID: 35434045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.